Citations

Showing 10 of 107851 citations.

Diagnostic accuracy of electronic medical record retrieval methods and a large language model for identifying cardiovascular events: a multisite retrospective validation study in a medical system in the United States
Ibrahim, Omar, Farina, Juan, Ibrahim, Omar , Awad, Kamal, Sheashaa, Hesham, Abdelfattah, Fatmaelzahraa E., Razaghi, Mahshad , Kaggal, Vinod C. , Arsanjani, Reza, Ayoub, Chadi , Ibrahim, Omar H , Villa Etchegoyen, Cecilia , Romero-Brufau, Santiago , Ibrahim, Omar H., Farina, J M, Awad, Kamal , Abbas, Mohammed Tiseer , Scalia, Isabel G. , Abdelfattah, Fatmaelzahraa , Etchegoyen, Cecilia Villa , Romero‐Brufau, Santiago , Arsanjani, Reza

Mayo Clinic

BMJ Open | August 13, 2026 | Volume: 16 | Issue: 8 | Pages: e116133

10.1136/bmjopen-2025-116133 | PMID 42595369 Get It

Objective To compare the diagnostic accuracy of four available automated electronic medical record (EMR) retrieval methods, including a large language model (LLM)-assisted workflow, against manual chart adjudication for identifying cardiovascular events. Design Retrospective diagnostic accuracy study. Setting Three sites within a single US tertiary health system. Participants Two adult cohorts with previously adjudicated cardiovascular outcomes were included. Cohort 1 included 2258 patients treated with immune checkpoint inhibitors, and Cohort 2 included 1426 patients who underwent transcatheter aortic valve replacement. Primary and secondary outcome measures The reference standard was clinician manual chart adjudication. Outcomes included ischaemic stroke or transient ischaemic attack, myocardial infarction (MI), heart failure (HF) exacerbation or hospitalisation and a composite major adverse cardiovascular events (MACE) outcome. Automated retrieval methods included International Classification of Diseases (ICD) codes, primary diagnosis, problem list and a zero-shot LLM workflow. Area under the (receiver operating characteristic) curve (AUC), sensitivity, specificity and net reclassification improvement were assessed. Results In Cohort 1, the LLM achieved the highest AUC for stroke (0.920; 95% CI 0.881 to 0.958), MI (0.938; 95% CI 0.905 to 0.971) and composite MACE (0.880; 95% CI 0.854 to 0.907), whereas ICD-based retrieval had a higher AUC for HF (0.882; 95% CI 0.845 to 0.918 vs 0.873; 95% CI 0.831 to 0.914). In Cohort 2, the LLM achieved the highest AUC for all evaluated outcomes: stroke (0.915; 95% CI 0.862 to 0.968), MI (0.928; 95% CI 0.839 to 1.000), HF (0.844; 95% CI 0.803 to 0.884) and composite MACE (0.862; 95% CI 0.829 to 0.895). In Cohort 1, differences in AUC between the LLM and ICD methods were not statistically significant across outcomes, whereas in Cohort 2 the LLM showed significantly higher AUC for stroke and composite MACE. Conclusion In this multisite retrospective validation study, the LLM-assisted workflow showed strong but context-dependent performance for identifying cardiovascular events from the EMR. Performance varied by outcome and cohort, and ICD-based retrieval remained competitive for some use cases. These findings support a complementary role for LLM-assisted extraction in retrospective cardiovascular outcomes research.
Novel Tetrahydropyridinyl-6,6-Bicyclic Compounds as 5-HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches
Sabnis, Ram W. , Sabnis, Anika R., Sabnis, Anika R.

Mayo Clinic

ACS Medicinal Chemistry Letters | August 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1021/acsmedchemlett.6c00430 | PMID 42741299 Get It

Abstract Provided herein are novel tetrahydropyridinyl-6,6-bicyclic compounds as 5-HT2A receptor agonists, pharmaceutical compositions, use of such compounds in treating depression, anxiety, substance abuse and headaches, and processes for preparing such compounds.
Key points from the 2026 multisocietal acute pulmonary embolism guidelines: Perspectives of some SVM members on the writing committee
Porres‐Aguilar, Mateo , Piazza, Gregory, Barnes, Geoffrey D. , Mukherjee, Debabrata , Secemsky, Eric A. , Creager, Mark A. , Porres-Aguilar, Mateo , Creager, Mark A , Secemsky, Eric A , Mukherjee, Debabrata , Piazza, Gregory

Mayo Clinic

Vascular Medicine | August 13, 2026 | Volume: 31 | Issue: 4 | Pages: 617-620

10.1177/1358863x261469140 | PMID 42591043 Get It

The electrocardiogram and artificial intelligence: turning signals into insights in pediatric and congenital heart disease
Leone, David, Asztalos, Ivor , Mayourian, Joshua, Asztalos, Ivor B, Mayourian, Joshua

Mayo Clinic

Current Opinion in Pediatrics | August 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/mop.0000000000001612 | PMID 42590997 Get It

Purpose of review Artificial intelligence applied to electrocardiography (AI-ECG) has rapidly been investigated in adult cardiovascular medicine, yet translation into pediatric and congenital heart disease populations has lagged. This review summarizes contemporary AI-ECG methodologies and emerging applications in pediatric and congenital heart disease (PCHD), with emphasis on current clinical utility, technical challenges, and future opportunities for implementation. Recent findings Recent studies demonstrate that deep learning models can accurately identify arrhythmias, ventricular dysfunction, and CHD from standard ECG. Convolutional neural networks remain the dominant architecture, although transformer-based foundation models and self-supervised learning approaches are increasingly being explored. AI-ECG applications in PCHD have expanded from automated interpretation toward proactive risk stratification, including prediction of ventricular dysfunction, mortality, and sudden cardiac death risk. Additional work has investigated wearable monitoring, telemetry analysis, and integration with longitudinal clinical data. Despite promising performance, most studies remain retrospective and single-center, with limited external validation and challenges related to small datasets, physiologic heterogeneity, and age-dependent ECG variation. Summary AI-ECG has the potential to transform PCHD by improving diagnostic accuracy, enabling earlier disease detection, and enhancing longitudinal risk assessment. Broader clinical implementation will require multicenter collaboration, prospective validation, standardized datasets, and careful attention to ethical, regulatory, and equity considerations.
Inter‐software variability of Centiloid quantification in amyloid PET: A head‐to‐head comparison of five software platforms
Zhang, Jun , MD, Miller, Dizdar, Nur, Johnson, Matthew P. , Bilgin, Cem, Kemp, Bradley J. , Durski, Jolanta M. , Lowe, Val, Johnson, Derek R., Burkett, Brian J. , Schwarz, Christopher G. , Bilgin, Cem , Lowe, Val J.

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | August 13, 2026 | Volume: 18 | Issue: 3 | Pages: No page available

10.1002/dad2.70443 | PMID 42597411 Get It

Abstract INTRODUCTION Centiloid (CL) scaling standardizes amyloid positron emission tomography (PET) quantification across tracers and platforms; however, variability across software implementations may affect diagnostic classification. This study evaluated inter‐software variability and diagnostic performance across five platforms using identical 1 8 F‐florbetapir datasets. METHODS Retrospectively, 192 patients undergoing 1 8 F‐florbetapir PET/computed tomography (CT) and magnetic resonance imaging (MRI) were analyzed. CL values were generated using four US Food and Drug Administration (FDA) ‐cleared platforms and an in‐house Centiloid standard pipeline. Agreement was assessed using intraclass correlation coefficient, with bias and limits of agreement evaluated by linear modeling and Bland–Altman analysis. Diagnostic performance was assessed using receiver operating characteristic (ROC) analysis and classification against visual interpretation. RESULTS Agreement was excellent (intraclass correlation coefficient [ICC] 0.969; 95%CI 0.961–0.975). Some platforms produced systematically higher CL values versus others slightly lower. LoA reached ± 30 CL. Diagnostic accuracy was high (area under the curve [AUC]: 0.949–0.975), with sensitivity 0.923–0.968 and specificity 0.667–0.806. DISCUSSION Despite excellent agreement, systematic differences persist and may affect classification near thresholds, supporting consistent use of a single processing pipeline.
The Financial Burden of Pancreatic Enzyme Replacement Therapy for Patients With Resected Pancreatic Cancer
Lu, Patricia G , Stucky, Chee-Chee, Potter, Alexandra, Yang, Chi‐Fu Jeffrey, Pannala, Rahul , Wasif, Nabil , Anderson, Michelle A., Chang, Yu‐Hui H., Lu, Patricia Gina , Chang, Yu‐Hui , Potter, Alexandra L. , Linderman, George C. , Yang, Chi‐Fu Jeffrey , Fong, Zhi Ven

Mayo Clinic

Journal of Surgical Oncology | August 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/jso.70361 | PMID 42590794 Get It

ABSTRACT Background Post‐pancreatectomy exocrine insufficiency is common after resection for pancreatic cancer and requires pancreatic enzyme replacement therapy (PERT). We sought to determine the out‐of‐pocket cost of PERT and the association between PERT and survival. Methods The SEER‐linked Medicare database was queried for patients with pancreatic cancer who underwent pancreaticoduodenectomy (PD) or distal pancreatectomy (DP) from 2010 to 2019. Cumulative out‐of‐pocket costs were calculated and stratified by procedure and radiation. Results 11,854 Medicare beneficiaries with resected pancreatic cancer were identified, 4,653 (39%) required PERT and 7,201 (61%) did not. Median age was 73.0, 50.6% were female and 83.6% White. 25.9% underwent DP and 74.1% underwent PD; 7% received neoadjuvant radiation while 23.5% received adjuvant radiation. Logistic regression demonstrated that female sex (OR 1.25, 95% CI 1.16‐1.35, p < 0.001), neoadjuvant radiation (OR 1.93, 95% CI 1.67‐2.24, p < 0.001), and PD (OR 2.45, 95% CI 2.23‐2.7, p < 0.001) were risk factors for requiring PERT. Patients without subsidies who underwent DP paid a cumulative $4,736 out‐of‐pocket for PERT after 5 years, those who underwent PD paid $5,601 out‐of‐pocket. Conclusions Nearly 40% of Medicare beneficiaries took PERT after resection for pancreatic cancer and paid thousands in out‐of‐pocket costs. While a conservative estimate, these findings highlight the importance of addressing this financial burden to patients.
Impact of Anterior Load Carriage on Dynamic Sagittal Spinal Alignment
Bhat, Sandesh G., Barman, Apurba, Kaufman, Kenton R , Barman, Apurba , Rezaei, Asghar , Bhat, Sandesh G. , Kaufman, Kenton R.

Mayo Clinic

American Journal of Physical Medicine & Rehabilitation | August 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/phm.0000000000003128 | PMID 42587358 Get It

Objectives: To examine the effects of anterior load carriage on dynamic sagittal spinal alignment during the gait cycle in younger (<65 y) and older (≥65 y) adults. Design: Cross-sectional study of 47 participants aged 20–80 years categorized as young and older adults. Participants walked at self-selected speeds with and without a 4.5 kg anterior chest load. Whole-body kinematics were recorded using a 19-camera infrared motion capture system. Outcome measures included lumbar lordosis (LL), thoracic kyphosis (TK), trunk inclination (TI), sagittal trunk shift (STS), and pelvic tilt (PT). Gait-cycle–dependent differences were analyzed using statistical parametric mapping. Results: The mean age was 41 years in young adults (n=28) and 70 years in older adults (n=19). Anterior load carriage increased LL during portions of the gait cycle and reduced TI throughout the entire gait cycle. Younger adults demonstrated greater LL and lower TI than older adults. A significant age-by-load interaction for TI was observed during portions of the gait cycle. Conclusions: Anterior load carriage alters spinal alignment by increasing LL and reducing TI during walking, with distinct age-related patterns. These results provide valuable reference data and a foundation for future studies on load management and ergonomic interventions across the adult lifespan.
Response to Ng et al. on “Stimulus‐induced arousal with transient electroencephalographic improvement distinguishes nonictal from ictal generalized periodic discharges”
Gélisse, Philippe , Tatum, William O. , Crespel, Arielle , Kaplan, Peter W , Kaplan, Peter W.

Mayo Clinic

Epilepsia | August 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/epi.70411 | PMID 42586957 Get It

In vitro evaluation of vancomycin-loaded Marlex mesh against staphylococci isolated from periprosthetic joint infection
Hellou, Mona Mustafa , Karau, Melissa J. , Perez, Sergio F. Guarin , Restrepo, Diego J. , Mandrekar, Jay, Bedard, Nicholas A. , Patel, Robin , Abdel, Matthew P. , Mustafa Hellou, Mona , Guarin Perez, Sergio F , Restrepo, Diego J. , Patel, Robin , Abdel, Matthew P , Bedard, Nicholas A , Mandrekar, Jay

Mayo Clinic

Bone & Joint Research | August 13, 2026 | Volume: 15 | Issue: 8 | Pages: 998-1004

10.1302/2046-3758.158.bjr-2025-0522.r2 | PMID 42586555 Get It

Aims Extensor mechanism disruption is a major complication following total knee arthroplasty, with treatment often consisting of extensor mechanism reconstruction utilizing monofilament polypropylene mesh (Marlex mesh, C. R. Bard, Inc). Infection following this procedure is devastating, often resulting in revision surgery and mesh removal, with permanent limb dysfunction. This study evaluated the in vitro ability of vancomycin-loaded polypropylene mesh to inhibit growth of isolates of three Staphylococcus species from patients with periprosthetic joint infection. Methods The mesh was prepared in two configurations – single-layer and eight-layer – and soaked for ten minutes in either sterile water (control) or vancomycin solution (50 mg/ml), after which the mesh was placed on tryptic soy agar plates inoculated with staphylococci and incubated at 37°C for 18 to 24 hours. Zones of inhibition were measured daily over seven days, with mesh transferred to freshly inoculated plates daily. Testing was performed in triplicate, with experiments repeated three times for each bacterial isolate. A total of 30 clinical isolates were tested (five methicillin-susceptible Staphylococcus epidermidis , five methicillin-resistant S. epidermidis , ten methicillin-resistant Staphylococcus aureus , and ten Staphylococcus lugdunensis ). Results Across all species, the eight-layer vancomycin-loaded mesh produced statistically significantly larger median zones of inhibition than the single-layer mesh. The antibacterial activity of the eight-layer mesh persisted through to day 7, while the single-layer mesh showed reduced activity by days 4 to 5. Conclusion Compared with single-layer vancomycin-loaded mesh, multilayer vancomycin-loaded mesh, which mimics clinical application, provides enhanced and sustained antibacterial activity in vitro. Cite this article: Bone Joint Res 2026;15(8):998–1004.
Assessment of Perceptions and Practices in Primary Care Providers Regarding Opportunistic Salpingectomy
Tischer, Kristin M. , Steiner, Amanda, Kelly, Camry , Stoll, Rebecca, Mohamed, Fahma , Selladurai, Roshini, Berbari, Elie, Hurt, Ryan, Kumar, Amanika, Bakkum-Gamez, Jamie N., Ehman, Katherine, Stoll, Rebecca , Selladurai, Roshini I. , Tischer, Kristin M. , Berbari, Elie F. , Bakkum‐Gamez, Jamie N.

Mayo Clinic

Journal of Primary Care & Community Health | August 12, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.1177/21501319261474095 | PMID 42586533 Get It

Introduction/Objective Opportunistic salpingectomy (OS) has been shown to reduce high-grade serous ovarian cancer (HGSOC) by 42-80%, yet awareness of this strategy outside of obstetrics and gynecology remains limited. The objective of this study was to assess awareness and counseling practices regarding OS for HGSOC prevention among primary care providers (PCPs). Methods We conducted a cross-sectional survey study using a 6-item electronic survey evaluating PCP knowledge and counseling practices related to HGSOC prevention through OS. The study was conducted at a single tertiary care center with gynecologic oncology services. Survey items assessed awareness of HGSOC origin, awareness of OS as a preventative strategy, counseling frequency in the setting of abdominal or pelvic surgery, counseling comfort, and resources needed to increase confidence in recommending OS. Response formats included Likert scales and Yes/No/Unsure options. The survey was distributed by email to attending physicians and advanced practice providers (APPs) in the Department of Family Medicine (FM) and Internal Medicine (IM). Results Of 398 providers surveyed, 136 responded (34% overall response rate; FM 44%, IM 28%), including 96 attending physicians and 40 APPs. Most PCPs were unaware that HGSOC originates in the fallopian tubes (60%) and were unaware of OS as a preventive strategy (71%). Counseling was uncommon: 11% had ever counseled on OS, while 74% had not and 15% reported it was outside their scope. Most respondents (63%) reported being not at all comfortable counseling patients about OS. Providers identified clinical guidelines (60%), CME or training modules (50%), eligibility criteria (48%), gynecology collaboration pathways (48%), and patient-friendly materials (44%) as key supports to improve counseling confidence. Conclusion PCP awareness and counseling regarding OS are limited. Given that guideline support for OS has solidified only in recent years, these gaps are not surprising—and they represent a clear, actionable opportunity. PCPs are well-positioned to lead the expansion of ovarian cancer prevention beyond specialty care with the right tools and support.